{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:38:23Z","timestamp":1767706703855,"version":"3.44.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Health and Medical Research Council (NHMRC) Medical and Dental Research Scholarship"},{"name":"Australian branch of the Thessalian Society"},{"name":"Diabetes Research Foundation, University of Sydney"},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["1037786"],"award-info":[{"award-number":["1037786"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fournier Laboratories"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.metabol.2015.12.008","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T23:46:44Z","timestamp":1450741604000},"page":"783-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Opposite associations between alanine aminotransferase and \u03b3-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study"],"prefix":"10.1016","volume":"65","author":[{"given":"Kathryn H.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey C.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej S.","family":"Januszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val J.","family":"Gebski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Manning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Mong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Donoghoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Ehnholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Buizen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Twigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony C.","family":"Keech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2015.12.008_bb0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10519-013-9593-y","article-title":"The genetic architecture of liver enzyme levels: GGT, ALT and AST","volume":"43","author":"van Beek","year":"2013","journal-title":"Behav Genet"},{"key":"10.1016\/j.metabol.2015.12.008_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10715760410001694026","article-title":"Is serum gamma glutamyltransferase a marker of oxidative stress?","volume":"38","author":"Lee","year":"2004","journal-title":"Free Radic Res"},{"key":"10.1016\/j.metabol.2015.12.008_bb0015","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.metabol.2014.03.008","article-title":"Circulating alanine transaminase (ALT) and \u03b3-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study","volume":"63","author":"Liu","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.008_bb0020","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/ATVBAHA.115.305235","article-title":"Circulating markers of liver function and cardiovascular disease risk","volume":"35","author":"Targher","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2015.12.008_bb0025","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ejim.2014.10.019","article-title":"Low ALT blood levels predict long-term all-cause mortality among adults. a historical prospective cohort study","volume":"25","author":"Ramaty","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.metabol.2015.12.008_bb0030","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/aje\/kwt209","article-title":"The association of low serum alanine aminotransferase activity with mortality in the US population","volume":"178","author":"Ruhl","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.metabol.2015.12.008_bb0035","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/gerona\/glq082","article-title":"The association of alanine transaminase with aging, frailty, and mortality","volume":"65","author":"Le Couteur","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.metabol.2015.12.008_bb0040","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0b013e318291cd29","article-title":"Association between ALT level and the rate of cardio\/cerebrovascular events in HIV-positive individuals: the D:A:D Study","volume":"63","author":"Sabin","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.metabol.2015.12.008_bb0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/liv.12311","article-title":"Serum liver enzymes are associated with all-cause mortality in an elderly population","volume":"34","author":"Koehler","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2015.12.008_bb0050","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/10715762.2014.902055","article-title":"Gamma-glutamyltransferase predicts increased risk of mortality: a systematic review and meta-analysis of prospective observational studies","volume":"48","author":"Long","year":"2014","journal-title":"Free Radic Res"},{"key":"10.1016\/j.metabol.2015.12.008_bb0055","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1373\/clinchem.2006.081620","article-title":"Gamma glutamyltransferase and long-term survival: is it just the liver?","volume":"53","author":"Kazemi-Shirazi","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2015.12.008_bb0060","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.2174\/138161211798220945","article-title":"Liver enzymes: potential cardiovascular risk markers?","volume":"17","author":"Lioudaki","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.metabol.2015.12.008_bb0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/er.2012-1009","article-title":"Diabetes and nonalcoholic fatty liver disease: a pathogenic duo","volume":"34","author":"Williams","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2015.12.008_bb0070","doi-asserted-by":"crossref","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Adipokines in nonalcoholic fatty liver disease. Metabolism 2015, http:\/\/dx.doi.org\/10.1016\/j.metabol.2015.11.006. [Epub ahead of print].","DOI":"10.1016\/j.metabol.2015.11.006"},{"key":"10.1016\/j.metabol.2015.12.008_bb0075","doi-asserted-by":"crossref","unstructured":"Brown GT, Kleiner DE. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism 2015, http:\/\/dx.doi.org\/10.1016\/j.metabol.2015.11.008. [Epub ahead of print].","DOI":"10.1016\/j.metabol.2015.11.008"},{"key":"10.1016\/j.metabol.2015.12.008_bb0080","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2015.12.008_bb0085","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications part 1: diagnosis and classification of diabetes mellitus\u2014provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2015.12.008_bb0090","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.metabol.2015.12.008_bb0095","first-page":"734","article-title":"IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 6. Reference procedure for the measurement of catalytic concentration of gamma-glutamyltransferase","volume":"40","author":"Schumann","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.metabol.2015.12.008_bb0100","first-page":"718","article-title":"IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase","volume":"40","author":"Schumann","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.metabol.2015.12.008_bb0105","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1002\/sim.5762","article-title":"Model selection in competing risks regression","volume":"32","author":"Kuk","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.metabol.2015.12.008_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/54433693-04e0-4f30-9a99-38fe3c5bb16b","article-title":"A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials","volume":"5","author":"Simes","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2015.12.008_bb0115","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10522-010-9287-2","article-title":"Aging, frailty and age-related diseases","volume":"11","author":"Fulop","year":"2010","journal-title":"Biogerontology"},{"key":"10.1016\/j.metabol.2015.12.008_bb0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12603-009-0010-4","article-title":"The SF-36: a simple, effective measure of mobility-disability for epidemiological studies","volume":"13","author":"Syddall","year":"2009","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.metabol.2015.12.008_bb0125","article-title":"Frailty and its impact on health-related quality of life: a cross-sectional study on elder community-dwelling preventive health service users","volume":"7","author":"Chang","year":"2012","journal-title":"PLoS One"},{"year":"2011","series-title":"User's manual for the SF-36v2 Health Survey","author":"Maruish","key":"10.1016\/j.metabol.2015.12.008_bb0130"},{"key":"10.1016\/j.metabol.2015.12.008_bb0135","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1056\/NEJMoa055373","article-title":"Multiple biomarkers for the prediction of first major cardiovascular events and death","volume":"355","author":"Wang","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2015.12.008_bb0140","first-page":"433","article-title":"Frailty syndrome: an overview","volume":"9","author":"Chen","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.metabol.2015.12.008_bb0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00223-013-9758-y","article-title":"Quality of life in sarcopenia and frailty","volume":"93","author":"Rizzoli","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.metabol.2015.12.008_bb0150","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/jhep.2001.22754","article-title":"Pseudocapillarization and associated energy limitation in the aged rat liver","volume":"33","author":"Le Couteur","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.12.008_bb0155","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/jsre.2002.6462","article-title":"Evaluation of the effect of age on functioning hepatocyte mass and liver blood flow using liver scintigraphy in preoperative estimations for surgical patients: comparison with CT volumetry","volume":"106","author":"Wakabayashi","year":"2002","journal-title":"J Surg Res"},{"key":"10.1016\/j.metabol.2015.12.008_bb0160","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.dld.2014.05.021","article-title":"Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age","volume":"46","author":"Vespasiani-Gentilucci","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.metabol.2015.12.008_bb0165","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.12.008_bb0170","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.12.008_bb0175","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.12.008_bb0180","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2014.11.030","article-title":"Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease","volume":"62","author":"Petta","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.12.008_bb0185","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.atherosclerosis.2014.10.004","article-title":"Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness","volume":"237","author":"Sunbul","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2015.12.008_bb0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2015.05.002","article-title":"Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease","volume":"241","author":"Chen","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2015.12.008_bb0195","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.metabol.2012.08.005","article-title":"In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not","volume":"62","author":"Younossi","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.008_bb0200","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00535-007-2060-x","article-title":"High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH","volume":"42","author":"Yoneda","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.metabol.2015.12.008_bb0205","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.12.008_bb0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0007114511000407","article-title":"Vitamin B-6: a challenging link between nutrition and inflammation in CVD","volume":"106","author":"Lotto","year":"2011","journal-title":"Br J Nutr"},{"key":"10.1016\/j.metabol.2015.12.008_bb0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-230X-12-69","article-title":"A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.metabol.2015.12.008_bb0220","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2014.11.024","article-title":"The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease","volume":"62","author":"Lazo","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.12.008_bb0225","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2337\/diabetes.51.6.1889","article-title":"High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes","volume":"51","author":"Vozarova","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2015.12.008_bb0230","first-page":"581","article-title":"Association of weight status with mortality in adults with incident diabetes","volume":"308","author":"Carnethon","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2015.12.008_bb0235","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2337\/dc12-0944","article-title":"Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality","volume":"36","author":"Logue","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.12.008_bb0240","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.atherosclerosis.2015.09.027","article-title":"Association between serum gamma-glutamyltransferase and the progression of coronary artery calcification","volume":"243","author":"Cho","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2015.12.008_bb0245","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/jech.2010.121830","article-title":"Impact of alcohol intake on total mortality and mortality from major causes in Japan: a pooled analysis of six large-scale cohort studies","volume":"66","author":"Inoue","year":"2012","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.metabol.2015.12.008_bb0250","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.atherosclerosis.2006.04.006","article-title":"Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study","volume":"191","author":"Schindhelm","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2015.12.008_bb0255","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/ije\/dyr172","article-title":"The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes","volume":"40","author":"Ford","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.metabol.2015.12.008_bb0260","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1016\/j.ijcard.2013.06.024","article-title":"Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels","volume":"168","author":"Tikkanen","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.metabol.2015.12.008_bb0265","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/09595239800187221","article-title":"Relations among alcohol consumption measures derived from the cognitive lifetime drinking history","volume":"17","author":"Russell","year":"1998","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.metabol.2015.12.008_bb0270","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.mol.0000252612.21602.e3","article-title":"Fenofibrate therapy and cardiovascular protection in diabetes: recommendations after FIELD","volume":"17","author":"Verges","year":"2006","journal-title":"Curr Opin Lipidol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604951500373X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604951500373X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:12:33Z","timestamp":1758427953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604951500373X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S002604951500373X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2015.12.008","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opposite associations between alanine aminotransferase and \u03b3-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}